President and CEO of Illumina Inc (30-Year Financial, Insider Trades) Francis A Desouza (insider trades) sold 3,000 shares of ILMN on 05/01/2020 at an average price of $308.61 a share. The total sale was $925,830.
Illumina Inc engages in life science tools and machines for analyzing genetic material. The company primarily engages in microarray and genome sequencing machines and disposables. It also provides sequencing services through its products. Illumina Inc has a market cap of $45.61 billion; its shares were traded at around $310.25 with a P/E ratio of 48.76 and P/S ratio of 12.93. Illumina Inc had annual average EBITDA growth of 23.20% over the past ten years. GuruFocus rated Illumina Inc the business predictability rank of 5-star.
CEO Recent Trades:
- President and CEO Francis A Desouza sold 3,000 shares of ILMN stock on 05/01/2020 at the average price of $308.61. The price of the stock has increased by 0.53% since.
- President and CEO Francis A Desouza sold 3,000 shares of ILMN stock on 04/06/2020 at the average price of $275. The price of the stock has increased by 12.82% since.
CFO Recent Trades:
- SVP and CFO Sam Samad sold 1,356 shares of ILMN stock on 04/20/2020 at the average price of $320.02. The price of the stock has decreased by 3.05% since.
- SVP and CFO Sam Samad sold 1,697 shares of ILMN stock on 04/16/2020 at the average price of $300. The price of the stock has increased by 3.42% since.
- SVP and CFO Sam Samad sold 249 shares of ILMN stock on 04/14/2020 at the average price of $292.54. The price of the stock has increased by 6.05% since.
Directors and Officers Recent Trades:
- SVP Chief Commercial Officer Oene Mark Van sold 625 shares of ILMN stock on 05/01/2020 at the average price of $316.83. The price of the stock has decreased by 2.08% since.
- SVP & General Counsel Charles Dadswell sold 121 shares of ILMN stock on 05/01/2020 at the average price of $317.16. The price of the stock has decreased by 2.18% since.
- Director Jay T Flatley sold 3,000 shares of ILMN stock on 04/21/2020 at the average price of $310.77. The price of the stock has decreased by 0.17% since.
- SVP Chief Medical Officer Phillip G. Febbo sold 173 shares of ILMN stock on 04/16/2020 at the average price of $300. The price of the stock has increased by 3.42% since.
- SVP Chief Commercial Officer Oene Mark Van sold 1,250 shares of ILMN stock on 04/16/2020 at the average price of $300.22. The price of the stock has increased by 3.34% since.
For the complete insider trading history of ILMN, click here
.
